| Bioactivity | Imiglucerase (Cerezyme) is a recombinant human glucocerebrosidase, ameliorates systemic manifestations such as hepatosplenomegaly, anemia, thrombocytopenia and skeletal abnormalities in patients with type 1 (non-neuronopathic) and type 3 (chronic neuronopathic) Gaucher's disease[1]. |
| Name | Imiglucerase |
| CAS | 154248-97-2 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Neal J Weinreb, et al. Imiglucerase and its use for the treatment of Gaucher's disease. Expert Opin Pharmacother. 2008 Aug;9(11):1987-2000. |